Literature DB >> 15294096

Effects of lipopolysaccharide on actin reorganization and actin pools in endothelial cells.

Qiao-bing Huang1, Li Song, Ke-sen Zhao, Bo Chen, Xu-liang Huang.   

Abstract

OBJECTIVE: To investigate the dose and time-dependent effects of lipopolysaccharide (LPS) on cytoskeletal F-acitn and G-actin reorganizations by visualizing their distribution and measuring their contents in human umbilical vein endothelial cell line ECV-304.
METHODS: F-actin was labeled with rhodamine-phalloidin and G-actin with deoxyribonuclease I (DNase I)conjugated with fluorescein isothiocyanate (FITC). Contents of cytoskeletal proteins were obtained by flow cytometry.
RESULTS: F-actin was mainly distributed peripherally in endothelial cells under normal conditions. LPS stimulation caused the formation of stress fibers and filopodia. G-actin was normally seen in perinuclear and nuclear areas in control ECV-304 cells. Under LPS stimulation, G-actin dots appeared in the cytoplasmic region. The actin disorganization was accompanied by the time- and dose- dependent decrease in F-actin pool and increase in G-actin pool.
CONCLUSIONS: LPS can induce characteristic morphological alterations of actin cytoskeleton and formation of intercellular gap in endothelial cells, accompanied by changes in F-actin and G-actin pools.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294096

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  2 in total

1.  Different contributions of clathrin- and caveolae-mediated endocytosis of vascular endothelial cadherin to lipopolysaccharide-induced vascular hyperpermeability.

Authors:  Ye Zhang; Lianyang Zhang; Yang Li; Shijin Sun; Hao Tan
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

2.  RAGE Plays a Role in LPS-Induced NF-κB Activation and Endothelial Hyperpermeability.

Authors:  Liqun Wang; Jie Wu; Xiaohua Guo; Xuliang Huang; Qiaobing Huang
Journal:  Sensors (Basel)       Date:  2017-03-30       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.